Cargando…
Assessing mortality differences across acute respiratory failure management strategies in Covid-19
PURPOSE: Prolonged observation could avoid invasive mechanical ventilation (IMV) and related risks in patients with Covid-19 acute respiratory failure (ARF) compared to initiating early IMV. We aimed to determine the association between ARF management strategy and in-hospital mortality. MATERIALS AN...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049881/ https://www.ncbi.nlm.nih.gov/pubmed/35490502 http://dx.doi.org/10.1016/j.jcrc.2022.154045 |
_version_ | 1784696240075702272 |
---|---|
author | Krishnan, Jamuna K. Rajan, Mangala Baer, Benjamin R. Hoffman, Katherine L. Alshak, Mark N. Aronson, Kerri I. Goyal, Parag Ezeomah, Chiomah Hill, Shanna S. Martinez, Fernando J. Turetz, Meredith L. Wells, Martin T. Safford, Monika M. Schenck, Edward J. |
author_facet | Krishnan, Jamuna K. Rajan, Mangala Baer, Benjamin R. Hoffman, Katherine L. Alshak, Mark N. Aronson, Kerri I. Goyal, Parag Ezeomah, Chiomah Hill, Shanna S. Martinez, Fernando J. Turetz, Meredith L. Wells, Martin T. Safford, Monika M. Schenck, Edward J. |
author_sort | Krishnan, Jamuna K. |
collection | PubMed |
description | PURPOSE: Prolonged observation could avoid invasive mechanical ventilation (IMV) and related risks in patients with Covid-19 acute respiratory failure (ARF) compared to initiating early IMV. We aimed to determine the association between ARF management strategy and in-hospital mortality. MATERIALS AND METHODS: Patients in the Weill Cornell Covid-19 registry who developed ARF between March 5 – March 25, 2020 were exposed to an early IMV strategy; between March 26 – April 1, 2020 to an intermediate strategy; and after April 2 to prolonged observation. Cox proportional hazards regression was used to model in-hospital mortality and test an interaction between ARF management strategy and modified sequential organ failure assessment (mSOFA). RESULTS: Among 632 patients with ARF, 24% of patients in the early IMV strategy died versus 28% in prolonged observation. At lower mSOFA, prolonged observation was associated with lower mortality compared to early IMV (at mSOFA = 0, HR 0.16 [95% CI 0.04–0.57]). Mortality risk increased in the prolonged observation strategy group with each point increase in mSOFA score (HR 1.29 [95% CI 1.10–1.51], p = 0.002). CONCLUSION: In Covid-19 ARF, prolonged observation was associated with a mortality benefit at lower mSOFA scores, and increased mortality at higher mSOFA scores compared to early IMV. |
format | Online Article Text |
id | pubmed-9049881 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90498812022-04-29 Assessing mortality differences across acute respiratory failure management strategies in Covid-19 Krishnan, Jamuna K. Rajan, Mangala Baer, Benjamin R. Hoffman, Katherine L. Alshak, Mark N. Aronson, Kerri I. Goyal, Parag Ezeomah, Chiomah Hill, Shanna S. Martinez, Fernando J. Turetz, Meredith L. Wells, Martin T. Safford, Monika M. Schenck, Edward J. J Crit Care Article PURPOSE: Prolonged observation could avoid invasive mechanical ventilation (IMV) and related risks in patients with Covid-19 acute respiratory failure (ARF) compared to initiating early IMV. We aimed to determine the association between ARF management strategy and in-hospital mortality. MATERIALS AND METHODS: Patients in the Weill Cornell Covid-19 registry who developed ARF between March 5 – March 25, 2020 were exposed to an early IMV strategy; between March 26 – April 1, 2020 to an intermediate strategy; and after April 2 to prolonged observation. Cox proportional hazards regression was used to model in-hospital mortality and test an interaction between ARF management strategy and modified sequential organ failure assessment (mSOFA). RESULTS: Among 632 patients with ARF, 24% of patients in the early IMV strategy died versus 28% in prolonged observation. At lower mSOFA, prolonged observation was associated with lower mortality compared to early IMV (at mSOFA = 0, HR 0.16 [95% CI 0.04–0.57]). Mortality risk increased in the prolonged observation strategy group with each point increase in mSOFA score (HR 1.29 [95% CI 1.10–1.51], p = 0.002). CONCLUSION: In Covid-19 ARF, prolonged observation was associated with a mortality benefit at lower mSOFA scores, and increased mortality at higher mSOFA scores compared to early IMV. Elsevier Inc. 2022-08 2022-04-28 /pmc/articles/PMC9049881/ /pubmed/35490502 http://dx.doi.org/10.1016/j.jcrc.2022.154045 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Krishnan, Jamuna K. Rajan, Mangala Baer, Benjamin R. Hoffman, Katherine L. Alshak, Mark N. Aronson, Kerri I. Goyal, Parag Ezeomah, Chiomah Hill, Shanna S. Martinez, Fernando J. Turetz, Meredith L. Wells, Martin T. Safford, Monika M. Schenck, Edward J. Assessing mortality differences across acute respiratory failure management strategies in Covid-19 |
title | Assessing mortality differences across acute respiratory failure management strategies in Covid-19 |
title_full | Assessing mortality differences across acute respiratory failure management strategies in Covid-19 |
title_fullStr | Assessing mortality differences across acute respiratory failure management strategies in Covid-19 |
title_full_unstemmed | Assessing mortality differences across acute respiratory failure management strategies in Covid-19 |
title_short | Assessing mortality differences across acute respiratory failure management strategies in Covid-19 |
title_sort | assessing mortality differences across acute respiratory failure management strategies in covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049881/ https://www.ncbi.nlm.nih.gov/pubmed/35490502 http://dx.doi.org/10.1016/j.jcrc.2022.154045 |
work_keys_str_mv | AT krishnanjamunak assessingmortalitydifferencesacrossacuterespiratoryfailuremanagementstrategiesincovid19 AT rajanmangala assessingmortalitydifferencesacrossacuterespiratoryfailuremanagementstrategiesincovid19 AT baerbenjaminr assessingmortalitydifferencesacrossacuterespiratoryfailuremanagementstrategiesincovid19 AT hoffmankatherinel assessingmortalitydifferencesacrossacuterespiratoryfailuremanagementstrategiesincovid19 AT alshakmarkn assessingmortalitydifferencesacrossacuterespiratoryfailuremanagementstrategiesincovid19 AT aronsonkerrii assessingmortalitydifferencesacrossacuterespiratoryfailuremanagementstrategiesincovid19 AT goyalparag assessingmortalitydifferencesacrossacuterespiratoryfailuremanagementstrategiesincovid19 AT ezeomahchiomah assessingmortalitydifferencesacrossacuterespiratoryfailuremanagementstrategiesincovid19 AT hillshannas assessingmortalitydifferencesacrossacuterespiratoryfailuremanagementstrategiesincovid19 AT martinezfernandoj assessingmortalitydifferencesacrossacuterespiratoryfailuremanagementstrategiesincovid19 AT turetzmeredithl assessingmortalitydifferencesacrossacuterespiratoryfailuremanagementstrategiesincovid19 AT wellsmartint assessingmortalitydifferencesacrossacuterespiratoryfailuremanagementstrategiesincovid19 AT saffordmonikam assessingmortalitydifferencesacrossacuterespiratoryfailuremanagementstrategiesincovid19 AT schenckedwardj assessingmortalitydifferencesacrossacuterespiratoryfailuremanagementstrategiesincovid19 |